This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
earnings-surprise: Archive
Atlassian (TEAM) Reports Q4 Earnings: What Key Metrics Have to Say
by Zacks Equity Research
The headline numbers for Atlassian (TEAM) give insight into how the company performed in the quarter ended June 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
TEAMNegative Net Change
earnings earnings-estimates-revisions earnings-surprise
Compared to Estimates, Con Ed (ED) Q2 Earnings: A Look at Key Metrics
by Zacks Equity Research
While the top- and bottom-line numbers for Con Ed (ED) give a sense of how the business performed in the quarter ended June 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
EDNegative Net Change
earnings earnings-estimates-revisions earnings-surprise
Here's What Key Metrics Tell Us About Block (XYZ) Q2 Earnings
by Zacks Equity Research
Although the revenue and EPS for Block (XYZ) give a sense of how its business performed in the quarter ended June 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
XYZNegative Net Change
earnings earnings-estimates-revisions earnings-surprise
Motorola (MSI) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
by Zacks Equity Research
While the top- and bottom-line numbers for Motorola (MSI) give a sense of how the business performed in the quarter ended June 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
MSIPositive Net Change
earnings earnings-estimates-revisions earnings-surprise
10x Genomics (TXG) Reports Q2 Earnings: What Key Metrics Have to Say
by Zacks Equity Research
Although the revenue and EPS for 10x Genomics (TXG) give a sense of how its business performed in the quarter ended June 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
TXGNegative Net Change
earnings earnings-estimates-revisions earnings-surprise
Alarm.com Holdings (ALRM) Q2 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Alarm.com (ALRM) delivered earnings and revenue surprises of +15.38% and +4.00%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
ALRMPositive Net Change SSTIPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Here's What Key Metrics Tell Us About VAREX IMAGING (VREX) Q3 Earnings
by Zacks Equity Research
While the top- and bottom-line numbers for VAREX IMAGING (VREX) give a sense of how the business performed in the quarter ended June 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
VREXPositive Net Change
earnings earnings-estimates-revisions earnings-surprise
Pinterest (PINS) Reports Q2 Earnings: What Key Metrics Have to Say
by Zacks Equity Research
While the top- and bottom-line numbers for Pinterest (PINS) give a sense of how the business performed in the quarter ended June 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
PINSNegative Net Change
earnings earnings-estimates-revisions earnings-surprise
Universal Electronics (UEIC) Q2 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Universal Electronics (UEIC) delivered earnings and revenue surprises of +260.00% and +4.58%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
UEICNegative Net Change GAUZPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Coherus Oncology (CHRS) Reports Q2 Loss, Beats Revenue Estimates
by Zacks Equity Research
Coherus Oncology (CHRS) delivered earnings and revenue surprises of -9.68% and +1.32%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
CHRSNegative Net Change FBIONegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Goodyear (GT) Reports Q2 Loss, Lags Revenue Estimates
by Zacks Equity Research
Goodyear (GT) delivered earnings and revenue surprises of -145.95% and -0.83%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
GTNegative Net Change WPRTPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Health Catalyst (HCAT) Q2 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Health Catalyst (HCAT) delivered earnings and revenue surprises of +33.33% and +0.24%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
HCATNegative Net Change FATENegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
MP Materials Corp. (MP) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
MP Materials (MP) delivered earnings and revenue surprises of +23.53% and +21.72%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
MPPositive Net Change DNNNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
TaskUs (TASK) Q2 Earnings and Revenues Top Estimates
by Zacks Equity Research
TaskUs (TASK) delivered earnings and revenue surprises of +26.47% and +7.89%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
TASKPositive Net Change NTNXNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
American Healthcare REIT (AHR) Tops Q2 FFO Estimates
by Zacks Equity Research
American Healthcare REIT (AHR) delivered FFO and revenue surprises of +5.00% and -0.42%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
AHRPositive Net Change ECCNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Amprius Technologies (AMPX) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
Amprius (AMPX) delivered earnings and revenue surprises of +37.50% and +16.66%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
AMPXPositive Net Change FTHMPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
AvePoint, Inc. (AVPT) Meets Q2 Earnings Estimates
by Zacks Equity Research
AvePoint (AVPT) delivered earnings and revenue surprises of 0.00% and +5.72%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
AVPTNegative Net Change EGANNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Metallus (MTUS) Q2 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Metallus (MTUS) delivered earnings and revenue surprises of +25.00% and +8.83%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
MTUSPositive Net Change GRWGPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Onto Innovation (ONTO) Q2 Earnings Lag Estimates
by Zacks Equity Research
Onto Innovation (ONTO) delivered earnings and revenue surprises of -1.57% and +1.54%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
ONTOPositive Net Change TLSNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Progyny (PGNY) Tops Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Progyny (PGNY) delivered earnings and revenue surprises of +9.09% and +3.22%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
PGNYNegative Net Change CODXPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Century Aluminum (CENX) Reports Q2 Loss, Lags Revenue Estimates
by Zacks Equity Research
Century (CENX) delivered earnings and revenue surprises of -114.71% and -3.47%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
CENXPositive Net Change LAKENegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
HA Sustainable Infrastructure Capital (HASI) Misses Q2 Earnings and Revenue Estimates
by Zacks Equity Research
HA Sustainable Infrastructure Capital (HASI) delivered earnings and revenue surprises of -3.23% and -75.50%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
HASIPositive Net Change BTCSPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
HCI Group (HCI) Q2 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
HCI Group (HCI) delivered earnings and revenue surprises of +15.88% and +1.57%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
HCIPositive Net Change AFCGPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Main Street Capital (MAIN) Q2 Earnings Meet Estimates
by Zacks Equity Research
Main Street Capital (MAIN) delivered earnings and revenue surprises of 0.00% and +4.92%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
MAINPositive Net Change ESNTPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
AbCellera Biologics Inc. (ABCL) Reports Q2 Loss, Beats Revenue Estimates
by Zacks Equity Research
ABCELLERA BIOLG (ABCL) delivered earnings and revenue surprises of +29.41% and +146.95%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
ABCLPositive Net Change XAIRPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank